# Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia

> **NCT00238043** · PHASE3 · UNKNOWN · sponsor: **Ministry of Health, Malaysia** · enrollment: 2000 (estimated)

## Conditions studied

- Chronic Kidney Disease
- End-Stage Renal Failure
- Anaemia

## Interventions

- **DRUG:** Biogeneric Epoetin

## Key facts

- **NCT ID:** NCT00238043
- **Lead sponsor:** Ministry of Health, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2011-04
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238043, "Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00238043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*